Detalles de la búsqueda
1.
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021.
Harm Reduct J
; 20(1): 142, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779203
2.
Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts.
J Viral Hepat
; 29(12): 1050-1061, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036117
3.
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
Am J Gastroenterol
; 116(9): 1896-1904, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34465693
4.
Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials.
J Viral Hepat
; 28(11): 1635-1642, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448313
5.
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 18(11): 2544-2553.e6, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32621971
6.
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study.
Adv Ther
; 40(8): 3465-3477, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285080
7.
Assessment of Drug-Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations.
Infect Dis Ther
; 12(8): 2057-2070, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470926
8.
Awareness and Epidemiology of Chronic Hepatitis C Virus Infections in Florida.
Infect Dis Ther
; 11(1): 451-462, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914078
9.
Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism.
Genet Vaccines Ther
; 9: 8, 2011 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-21477292
10.
Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts.
Adv Ther
; 38(6): 3409-3426, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34021887
11.
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019.
Adv Ther
; 38(12): 5777-5790, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704194
12.
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection.
Adv Ther
; 37(5): 2267-2274, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32279176
13.
Basolateral entry and release of New and Old World arenaviruses from human airway epithelia.
J Virol
; 82(12): 6034-8, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18417570
14.
Lentiviral vector gene transfer to porcine airways.
Mol Ther Nucleic Acids
; 1: e56, 2012 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-23187455
15.
Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha.
J Virol
; 77(10): 5902-10, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12719583
Resultados
1 -
15
de 15
1
Próxima >
>>